Omega Therapeutics is an epigenomic medicine company. Its drug development platform is focused on selectively directing the human genome to treat disease by controlling genomic expression without changing nucleic acid sequences. The company develops therapeutics for a range of disease indications, including rare genetic diseases, immunology, inflammation, metabolic diseases, and oncology.